Praxis Precision Medicines (PRAX) Enterprise Value (2022 - 2025)
Praxis Precision Medicines (PRAX) has 4 years of Enterprise Value data on record, last reported at -$242.0 million in Q4 2025.
- For Q4 2025, Enterprise Value rose 38.35% year-over-year to -$242.0 million; the TTM value through Sep 2025 reached -$267.2 million, up 25.17%, while the annual FY2025 figure was -$242.0 million, 38.35% up from the prior year.
- Enterprise Value reached -$242.0 million in Q4 2025 per PRAX's latest filing, up from -$267.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$56.0 million in Q2 2022 and bottomed at -$392.6 million in Q4 2024.
- Average Enterprise Value over 4 years is -$193.3 million, with a median of -$165.9 million recorded in 2023.
- Peak YoY movement for Enterprise Value: tumbled 382.86% in 2024, then soared 38.35% in 2025.
- A 4-year view of Enterprise Value shows it stood at -$61.6 million in 2022, then crashed by 31.95% to -$81.3 million in 2023, then tumbled by 382.86% to -$392.6 million in 2024, then surged by 38.35% to -$242.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$242.0 million in Q4 2025, -$267.2 million in Q3 2025, and -$301.3 million in Q2 2025.